Who owns GSK plc (GSK)? Elite investor 13F holders
11 tracked elite investors reported holding GSK plc as of 2026-06-30, including Dodge & Cox Funds, GMO, Aristotle Capital Management, D.E. Shaw, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
11 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology,…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dodge & Cox Funds | GSK PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 2526513684.00 USD | 48197514.000000 | Shares | reduce | Original filing |
| GMO | GSK PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 188686891.00 USD | 3599521.000000 | Shares | add | Original filing |
| Aristotle Capital Management | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 76719824.00 USD | 1463518.000000 | Shares | reduce | Original filing |
| Aristotle Capital Management | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 69253033.00 USD | 2633914.000000 | Shares | reduce | Original filing |
| D.E. Shaw | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 53439517.00 USD | 1019449.000000 | Shares | buy | Original filing |
| Bridgewater Associates | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 26428644.00 USD | 504171.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | GSK PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Kahn Brothers Group | GSK PLC | SHARE | 2026-06-30 | 2026-08-17 00:00:00 | 8305319.00 USD | 158438.000000 | Shares | reduce | Original filing |
| Hillman Capital Management | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 4842717.00 USD | 92383.000000 | Shares | reduce | Original filing |
| Tweedy Browne | GSK PLC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 4273645.00 USD | 81527.000000 | Shares | reduce | Original filing |
| Pzena Investment Management | GSK PLC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 1284635.00 USD | 24507.000000 | Shares | add | Original filing |
| Causeway Capital Management | GSK PLC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 375470.00 USD | 7163.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | GSK PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 71396.00 USD | 1362.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.